BNGO Bionano Genomics Inc

USD 1.11 0.02 1.834862
Icon

Bionano Genomics Inc (BNGO) Stock Analysis and Price Targets

COMMON STOCK | Medical Instruments & Supplies | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 1.11

+0.02 (+1.83)%

USD 0.06B

1.72M

USD 6.00(+440.54%)

USD 2.62 (+136.04%)

Icon

BNGO

Bionano Genomics Inc (USD)
COMMON STOCK | NSD
USD 1.11
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 0.06B

USD 2.62 (+136.04%)

USD 1.11

Bionano Genomics Inc (BNGO) Stock Forecast

USD 6.00
(+440.54%)

Based on the Bionano Genomics Inc stock forecast from 1 analysts, the average analyst target price for Bionano Genomics Inc is USD 6.00 over the next 12 months. Bionano Genomics Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Bionano Genomics Inc is Slightly Bearish, which is based on 3 positive signals and 5 negative signals. At the last closing, Bionano Genomics Inc’s stock price was USD 1.11. Bionano Genomics Inc’s stock price has changed by +4.72% over the past week, -12.60% over the past month and -89.53% over the last year.

No recent analyst target price found for Bionano Genomics Inc
No recent average analyst rating found for Bionano Genomics Inc

Company Overview Bionano Genomics Inc

Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result ...Read More

https://www.bionano.com

9540 Towne Centre Drive, San Diego, CA, United States, 92121

344

December

USD

USA

Adjusted Closing Price for Bionano Genomics Inc (BNGO)

Loading...

Unadjusted Closing Price for Bionano Genomics Inc (BNGO)

Loading...

Share Trading Volume for Bionano Genomics Inc Shares

Loading...

Compare Performance of Bionano Genomics Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BNGO

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Bionano Genomics Inc (Sector: Medical Instruments & Supplies )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ISRG
Intuitive Surgical Inc -1.01 (-0.25%) USD139.68B 78.19 61.43

ETFs Containing BNGO

Symbol Name BNGO's Weight Expense Ratio Price(Change) Market Cap

Frequently Asked Questions About Bionano Genomics Inc (BNGO) Stock

Based on ratings from 1 analysts Bionano Genomics Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 1 buy, sell and hold ratings.

Unfortunately we do not have enough data on BNGO's stock to indicate if its a good dividend stock.

Based on targets from 1 analysts, the average taret price for BNGO is USD 6.00 over the next 12 months. The maximum analyst target price is USD 6 while the minimum anlayst target price is USD 6.

Unfortunately we do not have enough data on BNGO's stock to indicate if its overvalued.

The last closing price of BNGO's stock was USD 1.11.

The most recent market capitalization for BNGO is USD 0.06B.

Based on targets from 1 analysts, the average taret price for BNGO is projected at USD 6.00 over the next 12 months. This means that BNGO's stock price may go up by +440.54% over the next 12 months.

We can't find any ETFs which contains Bionano Genomics Inc's stock.

As per our most recent records Bionano Genomics Inc has 344 Employees.

Bionano Genomics Inc's registered address is 9540 Towne Centre Drive, San Diego, CA, United States, 92121. You can get more information about it from Bionano Genomics Inc's website at https://www.bionano.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...